Rameda to be listed on EGX before end of 2019


Wed, 20 Nov 2019 - 03:37 GMT



CAIRO - 20 November 2019: Chairman of the Egyptian Financial Regulatory Authority (FRA) Mohamed Omran said that the authority approved Wednesday the listing of the shares of Rameda Pharmaceutical Company on the Egyptian Stock Exchange (EGX).

He clarified Wednesday during a conference announcing the issuance of the first short-term securitization for the payment of Premium Card that the first tranche of the offering ranges between LE 2 billion and LE 2.5 billion.

"According to the proposed schedule, the offering will be completed before the end of the year," he stated.

Rameda announced earlier its intention to offer a 35-45 percent stake in EGX by the end of last year through a capital increase and partial exits to shareholders.

The conference was attended by Founder and CEO of Premium International for Credit Services Paul Antaki, Co-Head of EFG Hermes' Investment Banking Division (IBD) Mostafa Gas, and CEO of Arab African International Bank Sherif Elwy.



Leave a Comment

Recommend Article

Be Social